Halozyme

Evotec $EVT (-15,85 %) saw its share price rise sharply today after reports emerged of a possible takeover by a US pharmaceutical group. $HALO (+6,85 %) have emerged. This news has caused the share price of the Hamburg-based biotechnology company, which specializes in drug discovery and development, to rise sharply. Analysts and investors are speculating about the strategic advantages such a deal could bring for both sides, particularly in a growing market for innovative drug research.

Personal opinion:

Should the takeover actually take place it would be a win-win situation for investors in both companies, as Evotec certainly has exciting projects underway.

Source:

https://www.t-online.de/finanzen/boerse/ticker/aktie-im-fokus-evotec-springen-hoch-moegliche-uebernahme/0DB2DE00629B99CE/

The news is based on what I personally consider to be reputable sources. However, I do not guarantee their accuracy. No advice.

"Ad hoc: Comment on media report

Hamburg - Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO)

The $EVT (-15,85 %) SE ("Company") notes with regard to a media report that, without prior contact, it received from the listed US biotechnology company$HALO (+6,85 %) Therapeutics Inc. regarding a takeover offer addressed to the shareholders of the Company with an offer price of EUR 11.00 per share. The company will carefully analyze this expression of interest, decide on further steps and inform the capital market in accordance with legal requirements.

End of the ad hoc announcement -"